ORAGENICS, INC. Amortization of Debt Discount (Premium)
ORAGENICS, INC. (OGEN) reported Amortization of Debt Discount (Premium) of $483.56 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-02-28
- ORAGENICS, INC. amortization of debt discount (premium) for the quarter ending 2012-12-31 was $0.00.
- ORAGENICS, INC. amortization of debt discount (premium) for the quarter ending 2012-09-30 was $443.97K.
- ORAGENICS, INC. amortization of debt discount (premium) for the quarter ending 2012-06-30 was $32.13K.
- ORAGENICS, INC. amortization of debt discount (premium) for the quarter ending 2012-03-31 was $7.46K.
- ORAGENICS, INC. amortization of debt discount (premium) for fiscal 2012 was $483.56K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $443.97K derived: sum of 2 quarters · filed 2014-02-28 | $476.10K derived: sum of 3 quarters · filed 2014-02-28 | $483.56K 10-K · filed 2014-02-28 |
| 2012-09-30 | $443.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | $476.10K derived: sum of 2 quarters · filed 2013-10-25 | $483.56K 10-Q · filed 2013-10-25 | |
| 2012-06-30 | $32.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $39.59K 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $7.46K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |